OpGen Provides Update on Curetis Group Business Receiving U.S. FDA 510(k) Clearance of its Unyvero LRT for BAL Specimens

NEXT STORY
Rubius Therapeutics Appoints Christina Coughlin, M.D., Ph.D., as Chief Medical Officer
PREV STORY
Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary Endpoint
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AB Science annonce que les résultats de l’étude AB07015 du masitinib dans l’asthme sévère ont été sélectionnés pour être présentés au colloque de l’ATS qui se tiendra le 16 octobre 2020

author_avatar
NASDAQ Market News

Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer

author_avatar
NASDAQ Market News

Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017

Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017 ...

author_avatar
NASDAQ Market News